Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Immix Biopharma, Inc. (IMMX) had Weighted-Average Shares Outstanding (Diluted) of 32.97M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-10.69M |
|
-- |
|
-- |
|
$10.89M |
|
$-10.89M |
|
$0.22M |
|
$-10.68M |
|
$-10.68M |
|
$-10.69M |
|
$-10.69M |
|
$-10.69M |
|
$-10.69M |
|
$-10.89M |
|
$-10.80M |
|
32.97M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
32.97M |
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$101.24M |
|
$2.52M |
|
$3.60M |
|
$104.84M |
|
$10.11M |
|
-- |
|
$0.93M |
|
$11.04M |
|
$93.80M |
|
$93.80M |
|
$93.80M |
|
52.95M |
|
| Cash Flow Statement Financials | |
$-23.93M |
|
$-7.21M |
|
$107.39M |
|
$17.68M |
|
$93.93M |
|
$76.25M |
|
$2.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.39% |
|
-11.39% |
|
-10.19% |
|
-11.39% |
|
$1.77 |
|
$-0.75 |
|
$-0.73 |
|